Figure 3 Nilotinib-targeting inhibits Pim1-mediated Th17 cell differentiation and alleviates the development of inflammatory arthritis (IMAGE)

Research

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Expert Contacts

Jiajie Lin
Department of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518000, China. Guangdong Provincial Clinical Research Center for Orthopedic Diseases, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518000, China.
linjj88@mail.sysu.edu.cn

Wenhui Yu
Department of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518000, China. Guangdong Provincial Clinical Research Center for Orthopedic Diseases, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518000, China.
yuwh5@mail2.sysu.edu.cn

Zhongyu Xie
Department of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518000, China. Center for Biotherapy, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518000, China. Guangdong Provincial Clinical Research Center for Orthopedic Diseases, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518000, China.
xiezhy23@mail.sysu.edu.cn

Figure 3 Nilotinib-targeting inhibits Pim1-mediated Th17 cell differentiation and alleviates the development of inflammatory arthritis (IMAGE)

Caption

Credit

Usage Restrictions

License